| Schedule of related party transactions |
| |
|
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
| |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
| |
|
|
|
|
|
|
|
|
| Sale and purchase of plasma |
|
|
|
|
|
|
|
|
| Product revenue |
|
$ 2,207,312 |
|
$ 2,808,640 |
|
$ 7,009,380 |
|
$ 7,262,915 |
| Purchases |
|
1,694,999 |
|
1,411,500 |
|
2,529,788 |
|
1,735,640 |
| |
|
|
|
|
|
|
|
|
| License revenue |
|
35,708 |
|
35,708 |
|
107,125 |
|
107,125 |
| |
|
|
|
|
|
|
|
|
| Interest expense |
|
230,000 |
|
230,000 |
|
682,500 |
|
290,000 |
| |
|
September 30, |
|
December 31, |
| |
|
2018 |
|
2017 |
| Accounts receivable |
|
$ 1,005,971 |
|
$ 1,245,677 |
| Accounts payable |
|
1,791,354 |
|
139,939 |
| Accrued expenses |
|
19,661 |
|
314,820 |
| Note payable, net of discount |
|
14,865,981 |
|
14,842,396 |
| Accrued interest |
|
292,500 |
|
65,000 |
| Deferred revenue |
|
2,582,908 |
|
2,690,033 |
|